MedPath

The effects of tranexamic acid on bleeding control

Phase 3
Conditions
Bleeding.
Hemorrhagic disorder due to extrinsic circulating anticoagulants
D68.32
Registration Number
IRCT20180625040232N4
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
108
Inclusion Criteria

Age between 18-65 years
ASA class >III
Not having coagulopathy

Exclusion Criteria

Need to embed Double J Stent
Prediction of need to transfusion during surgery
Patients with coagulopathy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath